Published in J Clin Endocrinol Metab on December 01, 1993
Bone Mineral Changes and Cardiovascular Effects among Female Athletes with Chronic Menstrual Dysfunction. Asian J Sports Med (2012) 0.81
Functional hypothalamic amenorrhea and its influence on women's health. J Endocrinol Invest (2014) 0.77
Serum Markers of Inflammation and Endothelial Function are Elevated by Hormonal Contraceptive Use but not by Exercise-Associated Menstrual Disorders in Physically Active Young Women. J Sports Sci Med (2006) 0.76
Magnitude of daily energy deficit predicts frequency but not severity of menstrual disturbances associated with exercise and caloric restriction. Am J Physiol Endocrinol Metab (2014) 0.76
Frequency of risk factors for ischaemic heart-disease in a healthy British population. With particular reference to serum-lipoprotein levels. Lancet (1974) 8.19
Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation (1999) 8.04
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med (2001) 7.69
Bone mineral content of amenorrheic and eumenorrheic athletes. N Engl J Med (1984) 3.69
Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest (1993) 2.89
Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J Clin Invest (1984) 2.53
Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL. Arterioscler Thromb Vasc Biol (2001) 2.42
Impaired superoxide production due to a deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice. Arterioscler Thromb Vasc Biol (2000) 2.41
Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation (1996) 2.05
Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. J Clin Invest (1986) 2.01
Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. Am J Pathol (1989) 1.87
Bone density at multiple skeletal sites in amenorrheic athletes. JAMA (1996) 1.72
Bromocriptine treatment of acromegaly. Br Med J (1975) 1.70
Human arterial wall cells secrete factors that are chemotactic for monocytes. Proc Natl Acad Sci U S A (1983) 1.64
Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density. Am J Med (1997) 1.63
The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J Biol Chem (1987) 1.61
Dietary compliance and cardiovascular risk reduction with a prepared meal plan compared with a self-selected diet. Am J Clin Nutr (1997) 1.57
Antioxidant vitamin supplementation and lipid peroxidation in smokers. Am J Clin Nutr (1998) 1.53
Transcriptional activation of the lipoprotein lipase and apolipoprotein E genes accompanies differentiation in some human macrophage-like cell lines. Biochemistry (1988) 1.52
Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins. Circulation (1998) 1.52
Ascorbic acid clearance in diabetic nephropathy. J Diabetes Complications (1998) 1.47
Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. J Lipid Res (1983) 1.46
Postnucleation droplet growth in supersaturated gas with arbitrary vapor concentration. J Chem Phys (2004) 1.44
Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques. J Clin Invest (1992) 1.40
Human erythroleukemia cell line (HEL) undergoes a drastic macrophage-like shift with TPA. Blood (1983) 1.37
Observations on the fate of large pulmonary emboli. Am J Roentgenol Radium Ther Nucl Med (1967) 1.35
Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding. J Clin Invest (1998) 1.32
Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway. J Clin Invest (1994) 1.31
Anti-tumor properties of blackseed (Nigella sativa L.) extracts. Braz J Med Biol Res (2007) 1.29
Physical activity, nutrition, and chronic disease. Med Sci Sports Exerc (1996) 1.28
Superoxide initiates oxidation of low density lipoprotein by human monocytes. Arteriosclerosis (1987) 1.26
Lipoprotein lipase secretion by human monocyte-derived macrophages. J Clin Invest (1982) 1.26
Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia. Eur J Clin Invest (1980) 1.25
Selective arteriography in the diagnosis of hemorrhage in the gastrointestinal tract. Radiol Clin North Am (1969) 1.22
Bone mineral density after resumption of menses in amenorrheic athletes. JAMA (1986) 1.21
Modification of low density lipoprotein by lipoprotein lipase or hepatic lipase induces enhanced uptake and cholesterol accumulation in cells. J Biol Chem (1988) 1.19
Low-density lipoprotein receptor activity in cultured human skin fibroblasts. Mechanism of insulin-induced stimulation. J Clin Invest (1979) 1.18
Serum lipoprotein abnormalities in patients with ischaemic heart disease: comparisons with a control population. Br Med J (1974) 1.16
Effect of bone density information on decisions about hormone replacement therapy: a randomized trial. Obstet Gynecol (1997) 1.15
Impact of patient weight on non-relapse mortality after marrow transplantation. Bone Marrow Transplant (1995) 1.14
Aerobic power of females, ages 10 to 68. J Gerontol (1975) 1.12
Renal vein thrombosis. Radiology (1968) 1.12
Phagocytosis of aggregated lipoprotein by macrophages: low density lipoprotein receptor-dependent foam-cell formation. Proc Natl Acad Sci U S A (1989) 1.12
Multicenter randomized trial of a comprehensive prepared meal program in type 2 diabetes. Diabetes Care (1999) 1.12
Influence of dietary fat on platelet function in men. Lancet (1973) 1.11
Plasma triglyceride and fatty acid metabolism in diabetes mellitus. Eur J Clin Invest (1972) 1.11
Vascular impressions on the ureters. Am J Roentgenol Radium Ther Nucl Med (1971) 1.11
Platelet-derived growth factor stimulates activity of low density lipoprotein receptors. Proc Natl Acad Sci U S A (1980) 1.11
Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice. J Nutr (1998) 1.10
Phagocytosis of opsonized oil droplets by neutrophils. Adaptation to a microtiter plate format. J Immunol Methods (1991) 1.09
Chylomicronemia syndrome in diabetes mellitus. Diabetes Care (1982) 1.08
In vivo assessment of architecture and micro-finite element analysis derived indices of mechanical properties of trabecular bone in the radius. Osteoporos Int (2002) 1.08
Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation? J Clin Invest (1994) 1.07
Type-III Hyperlipoproteinaemia ("remnant removal disease"). Insight into the pathogenetic mechanism. Lancet (1977) 1.05
Heterogeneity of primary lipoprotein lipase deficiency. Metabolism (1980) 1.05
Regulatory role of triiodothyronine in the degradation of low density lipoprotein by cultured human skin fibroblasts. J Clin Endocrinol Metab (1979) 1.05
The influence of the triglyceride content of low density lipoprotein on the interaction of apolipoprotein B-100 with cells. J Biol Chem (1988) 1.04
Clinical and metabolic study of alcoholic hyperlipidaemia. Lancet (1972) 1.04
Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cells and macrophages. Arterioscler Thromb Vasc Biol (1997) 1.04
Low density lipoprotein receptor activity in freshly isolated human blood monocytes and lymphocytes. Metabolism (1982) 1.03
The influence of oxidatively modified low density lipoproteins on expression of platelet-derived growth factor by human monocyte-derived macrophages. J Biol Chem (1991) 1.02
Experience with simplified scheme of treatment of hyperlipidaemia. Br Med J (1974) 1.00
Oxidized low density lipoproteins regulate synthesis of monkey aortic smooth muscle cell proteoglycans that have enhanced native low density lipoprotein binding properties. J Biol Chem (2000) 1.00
Oxidized LDL bind to nonproteoglycan components of smooth muscle extracellular matrices. J Lipid Res (2001) 1.00
Apolipoprotein E localization in human coronary atherosclerotic plaques by in situ hybridization and immunohistochemistry and comparison with lipoprotein lipase. Am J Pathol (1994) 1.00
Lipoprotein lipase gene expression in THP-1 cells. Biochemistry (1989) 0.99
Fatty streak expansion and maturation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis (1987) 0.99
Effect of dietary fructose on triglyceride transport and glucoregulatory hormones in hypertriglyceridemic men. Am J Clin Nutr (1979) 0.99
Regulation of the low density lipoprotein receptor and hydroxymethylglutaryl coenzyme A reductase genes by protein kinase C and a putative negative regulatory protein. Proc Natl Acad Sci U S A (1989) 0.98
Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes (1994) 0.98
Type III hyperlipoproteinemia: paradoxical hypolipidemic response to estrogen. Ann Intern Med (1977) 0.98
Functional overlap between "chylomicra" and "very low density lipoproteins" of human plasma during alimentary lipaemia. Atherosclerosis (1973) 0.97
Dietary antioxidants inhibit development of fatty streak lesions in the LDL receptor-deficient mouse. Arterioscler Thromb Vasc Biol (1998) 0.97
Women and exercise: physiological aspects. Exerc Sport Sci Rev (1984) 0.96
Reduction of serum triglyceride levels by polyunsaturated fat. Studies on the mode of action and on very low density lipoprotein composition. Atherosclerosis (1974) 0.95
Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins. Am J Med (2001) 0.95
Regulatory role of insulin in the degradation of low density lipoprotein by cultured human skin fibroblasts. Biochim Biophys Acta (1978) 0.95
Biglycan, a vascular proteoglycan, binds differently to HDL2 and HDL3: role of apoE. Arterioscler Thromb Vasc Biol (2001) 0.95
Lipoprotein lipase enhances the binding of native and oxidized low density lipoproteins to versican and biglycan synthesized by cultured arterial smooth muscle cells. J Biol Chem (1999) 0.95
Irreversible bone loss in former amenorrheic athletes. Osteoporos Int (1997) 0.94
In vivo stimulation of low-density lipoprotein degradation by insulin. Diabetes (1984) 0.93
Postprandial adipose tissue lipoprotein lipase activity in primary hypertriglyceridemia. Metabolism (1980) 0.92
Validity of estimating body fat of females: effect of age and fitness. Hum Biol (1977) 0.92
A double-blind randomized trial comparing outpatient parenteral nutrition with intravenous hydration: effect on resumption of oral intake after marrow transplantation. JPEN J Parenter Enteral Nutr (1997) 0.92
Age and aerobic power in women: a longitudinal study. J Gerontol (1979) 0.92
Oxidation of low density lipoprotein by thiols: superoxide-dependent and -independent mechanisms. J Lipid Res (1993) 0.91
Oxidative susceptibility of low density lipoprotein subfractions is related to their ubiquinol-10 and alpha-tocopherol content. Proc Natl Acad Sci U S A (1994) 0.91
Nutritionally complete prepared meal plan to reduce cardiovascular risk factors: a randomized clinical trial. J Am Diet Assoc (1999) 0.91
Hepatoportal arteriovenous fistula treated with detachable balloon embolotherapy. Am J Gastroenterol (1989) 0.90
Probucol treatment affects the cellular composition but not anti-oxidized low density lipoprotein immunoreactivity of plaques from Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb (1991) 0.90
Nutritional management of cardiovascular risk factors. A randomized clinical trial. Arch Intern Med (1997) 0.90
Autoregulation of the modified low density lipoprotein receptor in human monocyte-derived macrophages. Arteriosclerosis (1983) 0.90
Impaired very low density lipoprotein and triglyceride removal in broad beta disease: comparison with endogenous hypertriglyceridemia. Metabolism (1978) 0.90
Lipodystrophy with hyperlipidaemia: the role of insulin in very low density lipoprotein over-synthesis. Clin Endocrinol (Oxf) (1979) 0.89
Severe hypertriglyceridemia: role of familial and acquired disorders. Metabolism (1983) 0.89
Reduction of plasma triglyceride concentration by acute stress in man. Metabolism (1979) 0.88
Influence of exercise and heat stress on pulmonary function during ozone exposure. J Appl Physiol Respir Environ Exerc Physiol (1977) 0.88
Transcriptional activation of the lipoprotein lipase gene in macrophages by dexamethasone. Biochemistry (1991) 0.88
Response of prepubertal girls and college women to work in the heat. J Appl Physiol Respir Environ Exerc Physiol (1977) 0.88